Sana Device for PTSD
Post-Traumatic Stress Disorder (PTSD)
Pilot/Proof-of-ConceptActive
Key Facts
Indication
Post-Traumatic Stress Disorder (PTSD)
Phase
Pilot/Proof-of-Concept
Status
Active
Company
About Sana Health
Sana Health is a clinical-stage digital therapeutics company built on a founder's personal quest to overcome debilitating chronic pain. Its core technology is a wearable audiovisual device designed to modulate neural pathways to provide relief from conditions such as neuropathic pain and PTSD. The company has achieved significant regulatory milestones, including FDA Breakthrough Device Designation and submission of pivotal De Novo data for neuropathic pain, positioning it for potential market entry in a major indication. Backed by defense funding and a veteran team, Sana is advancing a pipeline focused on large, underserved neurological and psychiatric conditions.
View full company profileTherapeutic Areas
Other Post-Traumatic Stress Disorder (PTSD) Drugs
| Drug | Company | Phase |
|---|---|---|
| AL001 | Alzamend Neuro | Preclinical |
| PES200 | Virpax Pharmaceuticals | Discovery/Preclinical |
| Sequential Dialysis Technique | Halberd | Discovery |
| NeuroDirect™ Ketamine | Psycheceutical Bioscience | Phase 1 |
| MDMA-assisted therapy | Lykos Therapeutics | Phase 3 |
| Neuroplastogen Programs | Delix Therapeutics | Pre-clinical |
| TSND-201 (Methylone) | Transcend Therapeutics | Phase 2 |
| Phoenix CR | Evren Technologies | Unknown |
| Lu AG09222 | Lundbeck | Phase 2 |
| COMP360 Psilocybin Therapy | Compass Pathways | Phase 2 |
| NRX-101 | NRx Pharmaceuticals | Phase 2 |
| Ketamir-2 (Ketamir) | MIRA Pharmaceuticals | Phase 1 |